Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Litorina in connection with acquisition of Fresks
Mandate

Vinge advises Litorina in connection with acquisition of Fresks

January 15, 2016

The Oscarson family and the company’s former CEO will retain a significant shareholding together with Litorina and other key personnel within the company’s management.

Vinge’s team consisted of partners Johan Winnerblad and Louise Brorsson Salomon together with, among others, associates Charlotta Järnstedt, Helena Håkansson, Emil Fahlén Godö, Jasmin Draszka-Ali and Anne Wijkman. 

Related

Vinge advised Precise Biometrics

 Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

 Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026